List of Excipients in API vonoprazan fumarate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing vonoprazan fumarate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Phathom Pharmaceuticals Inc | VOQUEZNA | vonoprazan fumarate | 81520-100 | ASCORBIC ACID | 2032-05-03 |
| Phathom Pharmaceuticals Inc | VOQUEZNA | vonoprazan fumarate | 81520-100 | CELLULOSE, MICROCRYSTALLINE | 2032-05-03 |
| Phathom Pharmaceuticals Inc | VOQUEZNA | vonoprazan fumarate | 81520-100 | CROSCARMELLOSE SODIUM | 2032-05-03 |
| Phathom Pharmaceuticals Inc | VOQUEZNA | vonoprazan fumarate | 81520-100 | FERRIC OXIDE YELLOW | 2032-05-03 |
| Phathom Pharmaceuticals Inc | VOQUEZNA | vonoprazan fumarate | 81520-100 | FUMARIC ACID | 2032-05-03 |
| Phathom Pharmaceuticals Inc | VOQUEZNA | vonoprazan fumarate | 81520-100 | HYDROXYPROPYL CELLULOSE | 2032-05-03 |
| Phathom Pharmaceuticals Inc | VOQUEZNA | vonoprazan fumarate | 81520-100 | HYPROMELLOSE | 2032-05-03 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for vonoprazan fumarate
Excipient focus: ASCORBIC ACID
vonoprazan fumarate drug variants containing ASCORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Phathom Pharmaceuticals Inc | vonoprazan fumarate | 81520-100 |
| >Company | >Ingredient | >NDC |
vonoprazan fumarate drug variants not containing ASCORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
vonoprazan fumarate drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Phathom Pharmaceuticals Inc | vonoprazan fumarate | 81520-100 |
| >Company | >Ingredient | >NDC |
vonoprazan fumarate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
vonoprazan fumarate drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Phathom Pharmaceuticals Inc | vonoprazan fumarate | 81520-100 |
| >Company | >Ingredient | >NDC |
vonoprazan fumarate drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
vonoprazan fumarate drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Phathom Pharmaceuticals Inc | vonoprazan fumarate | 81520-100 |
| >Company | >Ingredient | >NDC |
vonoprazan fumarate drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FUMARIC ACID
vonoprazan fumarate drug variants containing FUMARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Phathom Pharmaceuticals Inc | vonoprazan fumarate | 81520-100 |
| >Company | >Ingredient | >NDC |
vonoprazan fumarate drug variants not containing FUMARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
vonoprazan fumarate drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Phathom Pharmaceuticals Inc | vonoprazan fumarate | 81520-100 |
| >Company | >Ingredient | >NDC |
vonoprazan fumarate drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
vonoprazan fumarate drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Phathom Pharmaceuticals Inc | vonoprazan fumarate | 81520-100 |
| >Company | >Ingredient | >NDC |
vonoprazan fumarate drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
vonoprazan fumarate drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Phathom Pharmaceuticals Inc | vonoprazan fumarate | 81520-100 |
| >Company | >Ingredient | >NDC |
vonoprazan fumarate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
vonoprazan fumarate drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Phathom Pharmaceuticals Inc | vonoprazan fumarate | 81520-100 |
| >Company | >Ingredient | >NDC |
vonoprazan fumarate drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
vonoprazan fumarate drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Phathom Pharmaceuticals Inc | vonoprazan fumarate | 81520-100 |
| >Company | >Ingredient | >NDC |
vonoprazan fumarate drug variants not containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
vonoprazan fumarate drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Phathom Pharmaceuticals Inc | vonoprazan fumarate | 81520-100 |
| >Company | >Ingredient | >NDC |
vonoprazan fumarate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch